Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis.

Trial Profile

Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs Etrolizumab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms EUCALYPTUS
  • Sponsors Genentech
  • Most Recent Events

    • 19 Oct 2016 Results (n=112) assessing Madcam-1 levels in serum, presented at the 24th United European Gastroenterology Week
    • 19 Oct 2016 Results (n=98) assessing VCAM-1 and ICAM-1 serum levels and expression, presented at the 24th United European Gastroenterology Week
    • 29 Oct 2015 Results of retrospective analysis of data from this trial published in the Gastroenterology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top